1. Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

   European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties, Sellner, L., Schetelig, J., Koster, L., Choi, G., Blaise, D., Beelen, D., Schianca, F. C., Passweg, J., Schanz, U., Gyan, E., Sora, F., Kröger, N., Wulf, G. G., Van Gorkom, G., Mayer, J., Orvain, C., Bourhis, J. H., Jindra, P., Potter, V., Zallio, F., Vandenberghe, E., Robinson, S., Hayden, P. J., Yakoub-Agha, I., Montoto, S. & Dreger, P., 2020, In : Bone marrow transplantation. 4 p.

   Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

2. Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Poor Karnofsky Performance Status Score. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

   Saraceni, F., Labopin, M., Forcade, E., Kroger, N., Socie, G., Niittyvuopio, R., Cornelissen, J., Labussiere-Wallet, H., Blaise, D., Choi, G., Byrne, J., Guillerm, G., Lamy, T., Esteve, J., Bazarbachi, A., Savani, B., Nagler, A. & Mohty, M., Mar-2020, In : Biology of Blood and Marrow Transplantation. 26, 3 Supplement, p. S108 1 p., Abstract 147.

   Research output: Contribution to journal › Meeting Abstract › Academic

3. Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (>= 60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT

   Heinicke, T., Labopin, M., Polge, E., Niederwieser, D., Platzbecker, U., Sengelov, H., Choi, G., Cornelissen, J., Blaise, D., Kuball, J., van Gorkom, G., Schaap, N., Potter, V., Paul, F., Savani, B. N., Nagler, A. & Mohty, M., Apr-2020, In : Bone marrow transplantation. 55, 4, p. 729-739 11 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. A haploidentical may be a better choice than a female genoidentical donor to transplant a patient with high risk acute myelogenous leukemia in first remission

   Gorin, N., Labopin, M., Blaise, D., Choi, G., Socie, G., Bourhis, J. H., Ciceri, F., Polge, E., Nagler, A. & Mohty, M., Jul-2019, In : Bone marrow transplantation. 54, p. 564-564 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

5. TKI discontinuation after allogeneic stem cell transplantation in patients with chronic myeloid leukemia (CML): A retrospective study from the chronic malignances working party (CMWP)

   de Lavallade, H., Eikema, D-J., Hoek, J., Robin, M., Itala-Remes, M., Passweg, J., Cornelissen, J., Ganser, A., Craddock, C., Aljurf, M., Choi, G., Nagler, A., Kroeger, N., Browne, P., Dreger, P., Scheid, C., Verbeek, M., Finke, J., Chalandon, Y. & Yakoub-Agha, I., Jul-2019, In : Bone marrow transplantation. 54, p. 52-54 3 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

View all (45) »